Skip to main content
. 2013 Jun 27;52(10):1809–1817. doi: 10.1093/rheumatology/ket224

Table 2.

Change scores from baseline to follow-up

Age <45 years (n = 217), mean (s.d.) Age 45–64 years (n = 823), mean (s.d.) Age ≥65 years (n = 488), mean (s.d.) P-value
ESR −7.2 (15.7) −4.07 (16) −6.82 (20.1) 0.08
TJC28 −3.81 (6.9) −2.64 (6.9) −2.41 (7.0) 0.001
SJC28 −2.61 (6.2) −2.32 (5.5) −2.01 (5.9) 0.16
Physician global VAS −13.4 (22.4) −12.9 (20.8) −11.4 (21.2) 0.15
Patient global VAS −8.34 (26.7) −9.83 (27.8) −7.39 (27.2) 0.10
MHAQ −0.09 (0.33) −0.09 (0.38) −0.05 (0.38) 0.02
CDAI −8.57 (14.2) −7.22 (13.1) −5.93 (13.5) 0.003
CDAI remission, % 19.82 13 11.27 0.01
CDAI category 0.045
Improve, % 57 50.7 44.42
No change, % 33.33 38.75 43.05
Worsen, % 9.66 10.55 12.53
Time baseline to follow-up, months 7.32 (3.6) 7.35 (3.5) 7.66 (3.9) 0.08